The objective of this paper is to further research the already established relationship between economic growth and health by using the results of some previous works and applying them on the recent data, in order to find out if the economic growth rate i

Priority setting and resource allocation across various health care functions is a critical issue in health policy and strategic decision making. As health resources are limited while there are so many health challenges to resolve, consumers and payers have to make difficult decisions about...

ABSTRACT The high price of cancer drugs has become a world-wide phenomenon. In recent decades, studies have produced ample evidence of rising research and clinical testing costs underlying pharmaceutical innovations. There is a general concurrence that the current model of drug development needs...

This is an effort at explaining the reasons and rationale behind the rising mortality rate (CDR) in the South Indian State – Andhra Pradesh. Although the state’s performance in socio-economic sphere seems to be not that impressive, its performance in demographic transition during the last...

This paper analyses possible options how to improve the risk adjustment of the health insurance system in the Czech Republic. From the possible options it argues for including pharmaceutical cost groups (PCGs) as additional risk factors since it is an improvement that can be implemented almost...

Hospitals hold a special place in the hearts of Canadians as the most visible representation of provinces’ commitment to publicly funded healthcare. As pillars of medicare and the centrepieces of provincial healthcare systems, hospitals are expected to be accessible when Canadians have...

CBO and the staff of the Joint Committee on Taxation have lowered their estimates of the net federal cost of the ACA’s insurance coverage provisions. As reflected in CBO’s April 2014 baseline, the agencies now project a cost of $36 billion for 2014, $5 billion less than the projection made...

This paper models the impact on economic growth of HIV/AIDS when the epidemic is in a mature phase, in contrast with previous studies focused on periods of expansion, as in African countries. Simulations for Honduras, the epicenter of the epidemic in Central America, show that AIDS is not likely...

The paper considers the characteristics of efficient health systems. First, indicators describing the health status of the population, then the determinant factors, finally their ratio was considered as the indicator of health system efficiency. The analysis indicates that Israeli health system...

Spending for Medicare's prescription drug program (Part D) was $50 billion in 2013—about 50 percent less than CBO projected when the program was created. Lower growth rates in national drug spending and lower-than-expected enrollment primarily account for the difference. The competitive design...